Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bismuth sodium tartrate is an inorganic compound containing bismuth, sodium, and tartrate ions. It is classified as a bismuth salt and functions as a coordination complex of bismuth, recognized by its chemical formula C4H2BiNaO6. Historically, bismuth tartrate compounds have had antimicrobial activity and have been studied and used in the treatment of gastrointestinal conditions and certain bacterial infections. The compound’s mechanism of action involves the antimicrobial property of bismuth ions, which disrupt microbial enzymes, and provide cytoprotective effects in the gastrointestinal tract. However, specific modern pharmaceutical indications and formulations of bismuth sodium tartrate are not widely documented; related bismuth tartrate salts (such as potassium bismuth tartrate) were used medicinally in the early 20th century[1][5]. Bismuth ions generally act as enzyme inhibitors, contributing to bactericidal effects, especially against Helicobacter pylori and related pathogens, and offer local protective properties on the gastric mucosa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bismuth sodium tartrate.